聚桂醇注射液治疗咽喉部血管瘤

目的 探讨局部注射聚桂醇注射液治疗咽喉部血管瘤的安全性、有效性及具体注射方式及剂量.方法 收集我科2015年10月~2016年12月的咽喉部血管瘤患者18例,单发血管瘤16例,散发血管瘤2例.依病变位置及深度以不同方式局部注射聚桂醇注射液治疗并观察其疗效.结果 所有患者经过3个月~1年随访,全部有效.其中1例多发性血管瘤患者注射聚桂醇注射液后局部反应性肿胀明显,3例轻度呼吸困难,10例术后疼痛.所有患者均未出现干咳、胸闷、血管栓塞、一过性缺血性休克及黑朦等较严重的不良反应.结论 聚桂醇注射液治疗咽喉部血管瘤安全可靠,疗效确切.具体注射方式需根据血管瘤的大小、深度等因素决定.

Lauromacrogol in treating laryngopharyngeal hemangioma

OBJECTIVE To investigate the safety, efficacy, specific injection mode and injection dose of Lauromacrogol for treating laryngopharyngeal hemangioma. METHODS a total of 18 patients with hemangioma of pharynx and larynx from Oct 2015 to Dec 2016 in were collected in our hospital. Among them, there were 18 cases of solitary hemangioma and 2 cases sporadic hemangioma. According to the location and depth of the lesions, different routes were used. Observe the therapeutic effect of local injection. RESULTS All the 18 patients were followed up for 3 months to 1 years. Among them, 1 case of multiple hemangioma patients were significantly affected by the local inflammatory swelling after the injection. 3 patients complained of mild dyspnea after operation, and 10 patients complained of postoperative pain. None of the patients had cough, chest tightness, embolism, adverse ischemic shock and severe amaurosis. CONCLUSION Lauromacrogol injection is safe, reliable and effective to treat hemangioma of pharynx and larynx. Different injection methods should be based on the size of hemangioma, depth and other factors.